Issue 21, 2023

A tris(2-aminoethyl)amine-based zinc complex as a highly water-soluble drug carrier for the anti-COVID-19 drug favipiravir: a joint experimental and theoretical study

Abstract

Tris(2-aminoethyl)amine (tren) coordinates to a Zn(II) ion to form the [Zn(tren)]2+ cation that accepts a monodentate favipiravir (FAV) anion. The results of this work show that the FAV anion is capable of binding to the [Zn(tren)]2+ cation through either a nitrogen or an oxygen atom (N/O-coordination). The energy decomposition analysis shows that, interestingly, both the strength and nature of the bonds between the [Zn(tren)]2+ cation and the N/O-coordinated FAV anion are almost the same. X-ray crystal structure determinations confirmed the existence of two types of cations in the solid state, [Zn(tren)(N-FAV)]+ and [Zn(tren)(O-FAV)]+. The NMR data, in a DMSO solution, were consistent with either the N-coordinated or the O-coordinated complex, but not a mixture of the two linkage isomers. The theoretical data indicated that the [Zn(tren)(N-FAV)]+ and [Zn(tren)(O-FAV)]+ cations have very similar stability in the gas phase, and in H2O, CH3OH, and DMSO solutions, and can also easily convert from one linkage isomer to the other. The experimental and theoretical data showed that, upon protonation of the above cations under acidic conditions (pH ≈ 3 to 5.5), the drug FAV will be easily released and replaced by a Cl anion, or an H2O molecule, which will coordinate to the zinc atom showing the potential of [Zn(tren)]2+ as a safe drug vehicle. Molecular docking studies using two well-known molecular docking packages show the relatively strong binding interactions of the [Zn(tren)(N-FAV)]+ and [Zn(tren)(O-FAV)]+ cations with DNA and viral protein macromolecules.

Graphical abstract: A tris(2-aminoethyl)amine-based zinc complex as a highly water-soluble drug carrier for the anti-COVID-19 drug favipiravir: a joint experimental and theoretical study

Supplementary files

Article information

Article type
Paper
Submitted
26 Jan 2023
Accepted
23 Feb 2023
First published
07 Mar 2023

Dalton Trans., 2023,52, 7031-7047

A tris(2-aminoethyl)amine-based zinc complex as a highly water-soluble drug carrier for the anti-COVID-19 drug favipiravir: a joint experimental and theoretical study

F. Hajibabaei, S. Sanei Movafagh, S. Salehzadeh and R. W. Gable, Dalton Trans., 2023, 52, 7031 DOI: 10.1039/D3DT00256J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements